Page last updated: 2024-11-11

citreoviridin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

citreoviridin: formed from Penicillium toxicarium, Penicillium citeoviride; Penicillium ochrosalmoneum on rice during storage [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436023
CHEMBL ID4456411
CHEBI ID80713
MeSH IDM0062930

Synonyms (20)

Synonym
brn 5311865
4-methoxy-5-methyl-6-(7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furyl)-1,3,5,7-octatetraenyl)-2h-pyran-2-one
2h-pyran-2-one, 4-methoxy-5-methyl-6-(7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furyl)-1,3,5,7-octatetraenyl)-
2h-pyran-2-one, 4-methoxy-5-methyl-6-(7-methyl-8-(tetrahydro-3,4-dihydroxy-2,4,5-trimethyl-2-furanyl)-1,3,5,7-octatetraenyl)-
nsc 159630
citreoviridin
25425-12-1
6-[(1e,3e,5e,7e)-8-[(2s,3r,4r,5r)-3,4-dihydroxy-2,4,5-trimethyloxolan-2-yl]-7-methylocta-1,3,5,7-tetraenyl]-4-methoxy-5-methylpyran-2-one
owx7q6cf4f ,
unii-owx7q6cf4f
CHEBI:80713
AKOS027288889
CHEMBL4456411
J-015992
Q27149750
DTXSID301017584
CS-W011696
HY-N6745
F85610
BC162714

Research Excerpts

Overview

Citreoviridin (CTV) is a mycotoxin that is produced by Penicillum citreonigrum, Aspergillus terreus and Eupenicillium ochrosalmoneum. It has been shown to be an inhibitor of mitochondrial F1-ATPases.

ExcerptReferenceRelevance
"Citreoviridin (CTV) is a mycotoxin produced by various fungi, including Penicillium citreonigrum. "( [Electrophysiological Effect of Citreoviridin on Human InducedPluripotent Stem Cell-derived Cardiomyocytes].
Kanda, Y; Kobayashi, N; Sugita-Konishi, Y; Uchiyama, Y; Yamazaki, D, 2022
)
2.45
"Citreoviridin (CTV) is a mycotoxin that is produced by "( Whole Genome Analysis Revealed the Genes Responsible for Citreoviridin Biosynthesis in
Izawa, K; Kobayashi, N; Okano, T; Sugita-Konishi, Y; Yoshinari, T, 2020
)
2.25
"Citreoviridin (CIT) is a mycotoxin produced by Penicillum citreonigrum, Aspergillus terreus and Eupenicillium ochrosalmoneum. "( Citreoviridin induces triglyceride accumulation in hepatocytes through inhibiting PPAR-α in vivo and in vitro.
Chen, M; Feng, C; Geng, C; Jiang, L; Li, D; Li, Q; Liu, X; Sun, X; Yang, G; Yao, X, 2017
)
3.34
"Citreoviridin (CIT) is a mycotoxin derived from fungal species in moldy cereals. "( Citreoviridin Induces Autophagy-Dependent Apoptosis through Lysosomal-Mitochondrial Axis in Human Liver HepG2 Cells.
Chen, M; Geng, C; Jiang, L; Li, Q; Liu, X; Liu, Y; Sun, X; Wang, Y; Yang, G; Yao, X, 2015
)
3.3
"Citreoviridin is a toxic metabolite from fungus that has been shown to be an inhibitor of mitochondrial F1-ATPases. "( Effect of citreoviridin and isocitreoviridin on beef heart mitochondrial ATPase.
Sayood, SF; Schuster, SM; Suh, H; Wilcox, CS, 1989
)
2.12

Toxicity

ExcerptReferenceRelevance
"The mycotoxin citreoviridin (CIT) isolated from Penicillium citreoviride was studied to elucidate the mechanism of its toxic actions."( Toxicity of citreoviridin.
Cole, RJ; Dorner, JW; Nishie, K, 1988
)
1.01

Bioavailability

ExcerptReferenceRelevance
" In vivo experiments revealed the high bioavailability of CTVD (116."( The In Vivo and In Vitro Toxicokinetics of Citreoviridin Extracted from
Kobayashi, N; Noguchi, M; Shiratori, N; Sugita-Konishi, Y; Takino, M; Uchiyama, Y, 2019
)
0.78

Dosage Studied

ExcerptRelevanceReference
" Six rats in each high-dose group died during the dosing period."( Teratogenic potential of the mycotoxin, citreoviridin, in rats.
Morrissey, RE; Vesonder, RF, 1986
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-pyranonesA pyranone based on the structure of 2H-pyran-2-one and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
ATP biosynthesis4015

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1616122Inhibition of F1F0-ATP synthase in yeast relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advancements in mechanistic studies and structure activity relationship of F
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (24.00)18.7374
1990's2 (4.00)18.2507
2000's2 (4.00)29.6817
2010's28 (56.00)24.3611
2020's6 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.78 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index5.60 (4.65)
Search Engine Demand Index35.06 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]